The second affiliated hospital of ChongQing medical university

Chongqing, Chongqing Municipality 400060

2 studies enrolling now · 7 studies all time

What they study most

Acute Myocardial Infarction (AMI), Cardiovascular Risk, Endometrial Cancer, HER2 Exon 20 Mutation, Heart Failure, Locally Advanced or Metastatic and Unresectable HCC, Non-squamous NSCLC, Renal Anemia, Type 2 Diabetes

Studies at this site

• A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed
• A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis — Completed
• A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC — Completed
• A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics — Completed